Recently, a single dose of the COVID-19 vaccine has been administered in many districts of Shanghai. According to the Shanghai Center for Disease Control and Prevention, different types of vaccines require different doses due to different research and development technology routes and production pro...
Adults infected with covid-19 three weeks after receiving one dose of the Pfizer-BioNTech or Oxford-AstraZeneca vaccine were 38-49% less likely to pass the virus on to their household contacts than people who were unvaccinated, a preprint released by Public Health England has shown.1 The ...
A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts.
Researchers from Bar-Ilan University and Ziv Medical Center now report preliminary evidence that people previously infected with the virus responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable...
authorization for its one-dose COVID vaccineBy Meg Oliver February 5, 2021 / 7:22 AM EST / CBS News A possible third COVID vaccine could be on the way in the U.S. It is sorely needed to ramp up vaccinations. Nearly 34 million Americans have had at least one COVID shot, but ...
In phase 3, J&J's vaccine was 66% effective overall at preventing moderate-to-severe COVID-19Johnson & Johnson (J&J) has submitted an application to the World Health Organization (WHO) seeking an emergency use listing (EUL) for its one-dose COVID-19 vaccine. The WHO subm...
Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those previously infected with SARS-CoV-2 is still not completely understood.
The southeast Asian nation launched a national vaccination campaign against COVID-19 in February 2021, with China being the key vaccine supplier. "Some 93.01 percent, or 14.88 million of the country's total population of 16 million, have taken at least one shot of COVID-19 vaccines," Vandin...
But vaccine shows reduced protection against one fast-spreading coronavirus variant. By Heidi Ledford Another vaccine has been shown to protect against COVID-19 — and this time, with only a single dose. Access options Access Nature and 54 other Nature Portfolio journals ...
US expert panel endorses Johnson & Johnson's one-dose COVID-19 vaccine; FDA will make final decision soon. By Associated Press | Feb. 26, 2021, at 5:04 p.m. Save More US Expert Panel Endorses Johnson & Johnson's One-Dose COVID-19 Vaccine; FDA Will ...